Following this program, participants should be able to:
List the appropriate pathology techniques for diagnosis and prognostic modeling for patients with hematologic malignancies
Identify the available therapeutic options for acute myeloid leukemia, chronic myelogenous leukemia, systemic light chain amyloidosis, multiple myeloma, mantle cell lymphoma, and low-grade lymphoma
Describe the clinically relevant subtypes of myelodysplastic syndromes and risk assessment with respect to their roles in selecting therapy
Define best practices for the management of supportive care issues including fever and neutropenia, thrombocytopenia, bone complications, and iron overload
